Recombinant biologics for treatment of bleeding disorders

Key Points Bleeding disorders and haemorrhage have an enormous social, medical and financial impact worldwide. Haemostasis is the process that arrests bleeding through the concerted activities of the vasculature, platelets and the plasma coagulation factors. Bleeding disorders can result from congen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Drug discovery 2004-08, Vol.3 (8), p.684-694
Hauptverfasser:	Bishop, Paul, Lawson, Jeff
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Biotechnology Blood Coagulation Disorders - drug therapy Blood Coagulation Disorders - epidemiology Blood Coagulation Disorders - etiology Blood Coagulation Factors - therapeutic use Cancer Research Care and treatment Hemorrhage - drug therapy Hemorrhage - etiology Hemorrhagic diseases Hemostasis Homeostasis - physiology Human immunodeficiency virus Humans Incidence Medicinal Chemistry Molecular Medicine Pharmacology/Toxicology Physiological aspects Recombinant molecules Recombinant Proteins - therapeutic use review-article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!